Balance Sheet for Anika Therapeutics Inc. (ANIK)

$ 35.39   1.21 (+3.54%) Volume: 167.18k 4:00 PM EDT Sep 30, 2020
After Hours:  $ 35.39 0.00 (0.00%) Volume: 1.5k 4:27 PM EDT Sep 30, 2020
Statement: View:
Assets [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Cash and Equivalents 157,463 89,042 133,256 104,261 110,707
Restrictable Cash - - - - -
Marketable Securities 27,480 69,972 24,000 20,500 27,751
Accounts Receivable 23,079 20,775 23,825 27,598 21,652
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 23,079 20,775 23,825 27,598 21,652
Inventories, Raw Materials 12,058 13,688 11,296 5,884 5,780
Inventories, Work in Progress 8,330 4,626 6,062 5,559 5,656
Inventories, Purchased Components - - - - -
Inventories, Finished Goods 8,777 6,819 4,677 4,540 3,502
Inventories, Other 14,825 17,467 22,035 15,983 14,938
Inventories, Adjustments & Allowances - - - - -
Inventories 21,995 21,300 22,035 15,983 14,938
Prepaid Expenses 4,289 1,854 3,211 2,098 1,385
Current Deferred Income Taxes - - - - 4,357
Other Current Assets 1,441 - - - -
Total Current Assets 234,306 202,943 206,327 170,440 176,433
Land and Improvements - - - - -
Buildings and Improvement 33,797 33,801 31,459 27,796 27,622
Machinery, Furniture and Equipment 44,937 41,660 39,084 28,582 25,752
Construction in Progress 559 2,720 5,830 22,695 11,274
Fixed Assets, Other 22,864 - - - -
Fixed Assets, Total 102,157 78,181 76,373 79,073 64,648
Gross Fixed Assets 102,157 78,181 76,373 79,073 64,648
Accumulated Depreciation (28,510) (24,070) (20,190) (26,777) (24,540)
Net Fixed Assets 73,647 54,111 56,183 52,296 40,108
Intangibles 7,585 9,191 10,635 10,227 11,656
Cost in Excess 7,694 7,851 8,218 7,214 7,482
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets 7,478 4,897 1,254 69 -
Total Non-Current Assets 96,404 76,050 76,290 69,806 59,315
Total Assets 330,710 278,993 282,617 240,246 235,748
Liabilities [+] in Thousands of Dollars
12/2019 12/2018 12/2017 12/2016 12/2015
Accounts Payable 3,832 3,143 6,747 2,303 8,302
Short Term Debt 1,141 - - - -
Notes Payable - - - - -
Accrued Expenses 5,474 3,315 3,433 3,176 1,696
Accrued Liabilities 5,474 3,315 3,433 3,176 1,696
Deferred Revenues - 126 - - 209
Current Deferred Income Taxes 794 (1,817) (1,198) (712) (1,594)
Other Current Liabilities 5,830 4,705 2,893 3,320 7,071
Total Current Liabilities 16,277 11,289 13,073 8,799 17,278
Long Term Debt N/A N/A N/A - -
Deferred Income Tax 4,331 3,542 5,393 6,548 6,775
Other Non-Current Liabilities 357 550 660 2,126 847
Minority Interest - - - - -
Capital Lease Obligations 21,367 - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - - - -
Total Non-Current Liabilities 26,055 4,092 6,053 8,674 7,622
Total Liabilities 42,332 15,381 19,126 17,473 24,900
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 288,378 263,612 263,491 222,773 210,848
Common Par 143 142 147 146 150
Additional Paid in Capital 48,707 50,763 68,617 61,735 81,685
Cumulative Translation Adjustments (5,898) (5,526) (4,784) (7,317) (6,649)
Retained Earnings 245,426 218,233 199,511 168,209 135,662
Treasury Stock - - - - -
Other Equity Adjustments (5,898) (5,526) (4,784) (7,317) (6,649)
Total Capitalization 288,378 263,612 263,491 222,773 210,848
Total Equity 288,378 263,612 263,491 222,773 210,848
Total Liabilities & Shareholder's Equity 330,710 278,993 282,617 240,246 235,748
Cash Flow 21,227 13,184 31,816 32,547 30,758
Working Capital 218,029 191,654 193,254 161,641 159,155
Free Cash Flow 34,178 30,262 31,832 9,787 29,839
Invested Capital 288,378 263,612 263,491 222,773 210,848
Shares Outstanding - Common Class Only 14,308 14,210 14,688 14,627 15,037
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 14,308 14,210 14,688 14,627 15,037
Total Common Shares Outstanding 14,308 14,210 14,688 14,627 15,037
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 14,121 14,442 14,575 14,682 14,934
Diluted Weighted Shares Outstanding 14,374 14,689 15,068 15,116 15,321